In the two studies in urticaria, the decrease in symptom score after six weeks of treatment with Neoclarityn was 58 and 67%, compared with 40 and 33% in placebo-treated patients.
Nõgestõve kahes uuringus vähenes Neoclarityni kuuenädalase ravi järel sümptomite punktisumma 58– 67%, platseeborühmas oli aga muutus 40– 33%.